References

[1]    Center MM, Jemal A. International Trends in Liver Cancer Incidence Rates. Cancer Epid Biomarkers & Prev. 20 (2011), 2362-8.  doi: 10.1158/1055-9965.EPI-11-0643. Epub 2011 Sep 15.

[2]    Liu Y,  Wu F. Global Burden of Aflatoxin-induced Hepatocellular Carcinoma: A Risk       Assessment.  Environ Health Perspect.  2010;118:818-24. doi: 10.1289/ehp.0901388. Epub       2010 Feb 19.         See also: Centers for Disease Control; Morbidity and Mortality Weekly Report. X, 2010;May 7: 517-5203.  

 [3]   Weir HK, Thompson TD, Soman A et al. Meeting the Healthy People 2020 Objectives to Reduce Cancer Mortality. Prev Chronic Dis. 2015;12:40482. DOI: 10.5888/pcd12.140482.

[4]    Ming LThorgeirsson SSGail MH et al. Dominant Role of Hepatitis B Virus and Cofactor Role of Aflatoxin in Hepatocarcinogenesis in Qidong, China.  Hepatology. 2002;36:1214-20. http://onlinelibrary.wiley.com/doi/10.1053/jhep.2002.36366/pd.

[5]    Ok HE, Kim HJ, Shim WB, Chum HS.  Natural occurrence of aflatoxin B1 in marketed foods and risk estimates of dietary exposure in Koreans. J Food Protect. 2007;70:2824-28.

 [6]   Muirhead, S. Pet Food varieties Recalled. Feedstuffs. 2006;16:3.  Settlement Agreement. http://recalledpetfoodsettlement.com/ (accessed 4 Jan. 2008)  see also:  http://www.nbcnews.com/id/10771943/ns/health-pet_health/t/toxic-pet-food-may-have-killed-dozens-dogs/#.UwKS9YXIehw          

 [7]   In Code of Federal Regulations: 7 CFR 983.150 Aflatoxin regulations. (a) maximum level. Wn. D.C.: US Government Publication Office. https://www.law.cornell.edu/cfr/text/7/983.150.  (accessed 15 Dec. 2016)

[8]    Giezendanner E, and Budd B. Aflatoxins, In Search of One Health Solutions (Power Point).

Gillings School of Public Health, University of North Carolina at Chapel Hill. In Collaboration with the North  Carolina One Health Collaborative. Copyright 2012.  (Also located at: www.pitt.edu/~super7/48011-49001/48591.ppt)        

 [9]   Nissen SB, Tjønneeland A, Stripp C, et al. Intake of A, C, and E from diet and supplements and breast cancer in postmenopausal women. Cancer Causes and Control. 2003;14:695-04.  DOI: 10.1023/A:1026377521890

[10]  Chen X, Mikhail SS, Ding YW,  Yang G, Bondoc F, and  Yang CS. Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats. Carcinogenesis. 2000;21:1531-6.

[11]  Factor VM, Laskowska D, Jensen MR et al. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. PNAS. 2000;97:2196-101.                

[12] Fariss MW, Fortuna MB, Everett CK, Smith JDTrent DFDjuric Z. The Selective Antiproliferative Effects of α-Tocopheryl Hemisuccinate and Cholesteryl Hemisuccinate on Murine Leukemia Cells Result from the Action of the Intact Compounds. Cancer Res. 1994;54:3346-51.

[13]  Yu W, Sander BG, Kline K. RRR-a-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res. 2003;63:2483-91.

[14] Israel K, Yu W, Sanders BG, Kline K. Vitamin E Succinate Induces Apoptosis in Human Prostate Cancer Cells: Role for Fas in Vitamin E Succinate-Triggered Apoptosis. Nutr & Cancer. 2000;36:90-100.

[15]   Exon JH, South EH, Taruscio TG, Clifton GD, Fariss MW. Chemopreventive Effect of       Dietary d-α-Tocopheryl Succinate Supplementation on Precancer Colon Aberrant Crypt         Formation and Vitamin E Analogue Levels in Young and Old Rats. Nutr & Cancer.         2004;49:72-80.  DOI:10.1207/s15327914nc4901_10

[16]  Tomasetti M, Andera L, Alleva R, Borghi B, Neuzil J, Procopio A. α-Tocopheryl succinate induces DR4 and DR5 expression by a p53 dependent route: Implication for sensitisation of resistant cancer cells to TRAIL apoptosis. FEBS Let. 2006;580:1925-31. DOI: 10.1016/j.febslet.2006.02.054

[17]  Weber T, Lu M, Andera L, Lahm H, Gellert N, Fariss MW. Vitamin E Succinate is a Potent Novel Antineoplastic Agent with High Selectivity and Cooperativity with Tumor Anti-necrosis Factor-Related Apoptosis-inducing Ligand (Apo2 Ligand) in Vivo. Clin Cancer Res. 2002;8:863-69.

 [18] Jha MN, Bedford JS, Cole WC,  Edward-Prasad J,  Prasad KN. Vitamin E (d-a-Tocopheryl     Succinate) Decreases Mitotic Accumulation in γ-irradiated Human Tumor, but Not in          Normal Cells. Nutr Cancer. 1999;35:189-94.  doi.org/10.1207/S15327914NC352_14.   

 [19]     Kumar B, Jha MN, Cole WC. D-Alpha-Tocopheryl Succinate (Vitamin E) Enhances Radiation-Induced Chromosomal Damage Levels in Human Cancer Cells, but Reduces it in Normal Cells. J. Am. Coll. Nutr. 2002;21:339-43. Doi.org/10.1080/07315724.2002.10719232.

[20]  Kline K, Yu W, Sanders BG. Vitamin E: Mechanisms of Action as Tumor Cell growth Inhibitors. In: Prasad KN,  Cole WC, editors. Cancer and Nutrition, Amsterdam: IOS Press; 1998; p. 37-9.

[21]  Traber MG, Packer L. Vitamin E: beyond antioxidant function. Am J Clin Nutr. 1995;62 Suppl:1501S-9S.

[22] Halver JE, Crystalline Aflatoxin and Other Vectors for Trout Hepatoma. In: Halver JE, Mitchell IA, editors. Trout Hepatoma Research Conference Papers. Wn. D.C.:  Bureau of Sport Fisheries and Wildlife; 1967, 78-102.

[23] Yu W, Simmonson-Menchaca M, Gapor A, Sanders BG, Kline K. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutrition & Cancer. 1999;33:26-32. Doi: 10.1080/01635589909514744.

 [24] Camargo FC, Gokhale S, Johnnidis JB, et al. YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells. Current Biology. 2007;17:2054-60. doi: 10.1016/j.cub.2007.10.039.

[25]  Dong J, Feldmann G, Huang J et al. Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals. Cell. 2007;130:1120-33. doi:10.1016/j.cell.2007.07.019.

[26]  Lu L, Li Y, Kim SM. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci. 2010;107:1437-42.  doi:10.1073/pnas.0911427107, 

[27]  Lee K, Lee JH, Kim TS, et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci. 2010;107:8248-53. DOI: 10.1073/pnas.0912203107

[28]  Ozoren N, El-Deiry WS.  Defining Characteristics of Types I and II Apoptotic Cells in Response to TRAIL. Neoplasia. 2002; 4:551–7. doi: 10.1038/sj.neo.7900270

[29]  Garg NK, Mangal S, Sahu T, Mehta  A, Vyas SP, Tyagi RK. Evaluation of anti-apoptotic activity of different dietary antioxidants in renal cell carcinoma against hydrogen peroxide. Asian Pac J Trop Biomed. 2011;1:57-63. doi:  10.1016/S2221-1691(11)60069-5.

[30]  Azizova YV, Teplyi DL, Bazhanova ED, Pozdnyakova ON. The effect of water deprivation and α-tocopherol acetate on the expression of apoptosis marker proteins. Advances in Gerontology. 2012;2:38-42. doi:10.1134/S2079057012010031.

[31]  Zang Y, Beard RL, Chandraratna, Kang JX. Evidence of lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukema HL-60cells. Cell Death Differ. 2001;8:477-85. doi: 10.1038/sj.cdd.4400843.

[32]  Zhou LL, ZhouLY, Luo KQ, Chang DC. Smac/DIABLO and cytochrome c are released from mitochondria through a similar mechanism during UV-induced apoptosis. Apoptosis. 2005;10:289-99. DOI: 10.1007/s10495-005-0803-9.

[33]  Aguiano-Hernandez YM, Chartier A, Huerta S. Smac/DIABLO and colon cancer. Anticancer Agents Med Chem. 2007;7:467-73. DOI: 10.2174/187152007781058631.

[34]  Deng Y, Lin Y, Wu X. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev. 2002;16:33-45. DOI: 10.1101/gad.949602.

[35]  Dong L, Jameson VJA, Tilly D et al. Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex. J Biol Chem. 2011;286:3717-28. DOI: 10.1074/jbc.M110.186643.

[36]  Rohlena J, Dong LF, Kluckova K et al. Mitochondrially Targeted α-Tocopheryl Succinate is Antiangiogenic: Potential Benefit Against Tumor Angiogenesis but Caution Against Wound Healing. Antioxid Redox Signal. 2011;15:2923-35.  DOI: 10.1089/ars.2011.4192.

[37]  Neuzil J, Tomasetti M, Zhao Y, Dong LF, Birringer M, Wang XF. Vitamin E Analogs, a Novel Group of “Mitocans,” as Anticancer Agents: The importance of Being Redox-Silent. Mol Pharmacol. 2007;71:1185-99. DOI: 10.1124/mol.106.030122.

[38]  Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl  JK . Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 1995;3:673-82. DOI: 10.1016/1074-7613(95)90057-8.

[39]   Wu K, Li Y, Zhao Y et al. Roles of Fas signaling pathway in vitamin E succinate-induced    apoptosis in human gastric cancer SGC-7901 cells. World J Gastroenterol. 2002;8:982–6.          DOI: 10.3748/wjg.v8.i6.982.

[40]  Tomasetti M, Rippo MR, Alleva R et al. Alpha-tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells. Br J Cancer. 2004;90:1644-53.  DOI: 10.1038/sj.bjc.6601707.

[41]  Hou L, Zhang H, Xu P  et al. Effect of vitamin E succinate on expression of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor in gastric cancer cells and CD4(+) T cells. Mol Biosyst. 2015;11:3119-28. DOI: 10.1039/c5mb00350d.

[42]  Kline K, Yu W, Sanders BG. The Role of Nutrition in Preventing and Treating Breast and Prostate Cancer. J Nutr. 2001:131:161S-3S.

[43]  Neuzil J, Weber T, Gellert N, Weber C. Selective cancer cell killing by α-tocopheryl succinate. Br J Cancer. 2000;84:87-9. DOI: 10.1054/bjoc.2000.1559

[44]  Ohlsson B, Albrechtsson E, Axelson J. Vitamins A and D but not E and K decreased the cell number in human pancreatic cancer cell lines. Scand J Gastroenterol. 2004;39:882-5. DOI: 10.1080/00365520410006701.

[45]   Kim HN, Lee JH, Jin WJ, Lee ZH. α-Tocophery Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption. J Bone Metab. 2012;111-20. DOI: 10.11005/jbm.2012.19.2.111.

[46]  Yu W, Heim K, Qian M, Simmons-Menchaca M, Sanders BGKline K. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinated-induced apoptosis of human MDA-MB-435 breast cancer cells. Nutr Cancer. 1997;27:267-78. DOI: 10.1080/01635589709514537

 [47] Turley JM, Fu T, Ruscetti FW, Mikovits JABertolette DC 3rdBirchenall-Roberts MC. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res. 1997;57:881-90.  pubmed/9041190     (See also: Malafa MP, Neitzel LT. Vitamin E succinate promotes breast cancer tumor dormancy. J. Surg Res. 2000;93:163-70. DOI: 10.1006/jsre.2000.5948.)

[48]  Kline K, Yu W, Sanders BG. Vitamin E and breast cancer. J Nutr. 2004;134:3458S-62S. pubmed/15570054.

[49]   Charpentier A, Simmons-Menchaca M, Yu W, Zhao B, Qian M, Heim K. RRR- α-            tocopheryl succinate enchances  TGF-beta 1, -beta 2, and beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells. Nutr. Cancer. 1996;26:237-50. DOI: 10.1080/01635589609514480.

[50]  Lim SJ, Lee YJ, Park DH et al. Alpha-tocopheryl succinate sensitizes human colon cancer cells to exisulind-induced apoptosis. Apoptosis. 2007;12:423-31. DOI: 10.1007/s10495-006-0620-9.

[51]  Neuzil J, Weber T, Schroder A et al. Induction of cancer cell apoptosis by α-tocopheryl succinate: molecular pathways and structural requirements. FASEB J. 2001;15:403-15. DOI: 10.1096/fj.00-0251com.

[52]  Sun Y, Zhao Y, Hou L, Zhang X, Zhang Z,Wu k. RRR-α-tocopheryl succinate induces apoptosis in human gastric cancer cells via the NF-κB signaling pathway. Oncol Rep. 2014;32:1243-8. DOI: 10.3892/or.2014.3282

[53]  Zhao Y, Li R, Xia W, Neuzil J, Lu Y, Zhang H. Bid integrates intrinsic and extrinsic signaling in apoptosis induced by alpha-tocopheryl succinate in human gastric carcinoma cells. Cancer Let. 2010;288:42-9. DOI: 10.1016/j.canlet.2009.06.021.

[54]  Abd-El Fattah AA, Darwish HA, Fathy N, Raafat A, Shouman SA. Promising antitumor effect of alpha-tocopheryl succinate in human colon and liver cancer cells. Med Chem Res. 2012;21:2735-2743. DOI: 10.1007/s00044-011-9801-3.

[55]  Valis K, Prochazka L,  Boura EChladova JObsil TRohlena J. Hippo/Mst1 Stimulates Transcription of the Proapoptotic Mediator NOXA in a Fox01-Dependent Manner. Cancer Res. 2011;71:946-54. DOI: 10.1158/0008-5472.CAN-10-2203.

[56]  Dalen J, Neuzil J. α-Tocopheryl succinate sensitizes a T Lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-κB activation. Br J Cancer. 2003;88:153-8. DOI: 10.1038/sj.bjc.6600683.

[57]  Turley JM, Funakoshi S, Ruscetti FW et al. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta. Cell Growth Differ.  1995;6:655-63.  pubmed/7669719.

[58]  Kovarova J, Bajzikova M, Vondrusova M, Stursa J, Goodwin J, Nguyen M. Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy. Redox Rep. 2014;19:16-25.  DOI: 10.1179/1351000213Y.0000000064

 [59]Patacsil D, Osayi S, Tran AT  et al. Vitamin E succinate inhibits survivin and induces apoptosis in pancreatic cancer cells. Genes Nutr. 2012;71:83-9. DOI:10.1007/s12263-011-0242-x.

[60]  Heisler T, Towfigh S, Simon N, Liu CMcFadden DW.. Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth. J Surg Res. 2000;88:23-5.  DOI: 10.1006/jsre.1999.5775.

[61]  Greco E, Basso D, Fadi E et al. Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. Pancreas.2010;39:662-8. DOI: 10.1097/MPA.0b013e3181c8b48c

[62]  Peng L, Liu X, Qian L, Tang TYang Z. Vitamin E Intake and Pancreatic Cancer Risk: Meta-Analysis of Observational Studies. Med Sci Monit. 2015;21:1249-55. DOI: 10.12659/MSM.893792.

[63]  Asanuma K, Moriai R, Yajima T et al. Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res. 2000;91:1204-9.  PMID: 11092988

[64]  Zhang Y, Ni J, Messing EM, Chang EYang CRYeh S.  Vitamin E succinate inhibits the function of androgen-specific antigen in prostate cancer cells. Proc Natl Acad Sci. 2002;99:7408-13. DOI: 10.1073/pnas.102014399.

[65]  Ni J, Chen M, Zhang Y, Li RHuang JYeh S. Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery. Biochem Biophys Res Comm. 2003;300:357-363.  PMID: 12504091.

[66]  Tomasetti M, Nocchi L, Neuzil J et al. Alpha-Tocopheryl Succinate Inhibits Autophagic Survival of Prostate Cancer Cells Induced by Vitamin K3 and Ascorbate to Trigger Cell Death. PLOS One. 2012;7:52263.  DOI: 10.1371/journal.pone.0052263.

[67]  Weinstein SJ, Peters U, Ahn J et al. Serum α-tocopherol and γ-tocopherol Concentrations and Prostate Cancer Risk in the PLCO Screening Trial: A Nested Case-Control Study.  PLOS One. 2012;7:e40204. DOI: 10.1371/journal.pone.0040204

[68]   Basu A, Grossie B, Bennett M, Mills NImrhan V. Alplha-tocopheryl succinate (α-TOS) modulates human prostate LNCap xenograft growth and gene expression in BALB/c         nude mice fed two levels of dietary soybean oil. Eur J Nutr. 2007;46:34-43. DOI:           10.1007/s00394-006-0629-4.

[69]  Smela ME, Currier SS, Bailey EA, Essigmann JM. The chemistry and biology of aflatoxin   B1: from mutational spectrometry to carcinogenesis. Carcinogenesis. 2001;22:535-45.       PMID: 11285186.

[70]   Kumar V. Aflatoxins, their Biosynthetic Pathway and Mechanism of Action.          biotecharticles.com./Agriculture-Article/Aflatoxins-their-Biosynthetic-Pathway-and-     Mechanism-of-Action-3357.html. [accessed 16.12.16]

[71]   Qiugang M, Li Y, Fan Y et al. Molecular Mechanisms of Lipoic Acid Protection against    Aflatoxin B1-Induced Liver Oxidative Damage and Inflammatory Responses in Broilers.        Toxin. 2015;7:5435-47. DOI: 10.3390/toxins7124879.

[72]   Leudde T, Schwabe F. NF-κβ in the liver-linking injury, fibrosis and hepatocellular       carcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:108-18. DOI: 10.1038/nrgastro.2010.213.

[73]   Meki AR, Abdel-Ghaffar SK, El-Gibaly I. Aflatoxin B1 induces apoptosis in rat liver:        protective effect of melatonin. Neuro Endocrinol Lett. 2001;22:417-26. PMID: 11781538.

[74]   Stern MC, Umbach DM, Yu MC, London SJZhang ZQTaylor JA. Hepatitis B, Aflatoxin   B1 and p53 Codon 249 Mutation in Hepatocellular Carcinomas from Guangxi, People's Republic of China and a Meta-analysis of Existing Studies. Cancer Epidemiol Biomarkers Prev. 2001;10:617-25.  PMID: 11401911

[75]   Mace L, Aguilar F, Wang JS et al. Aflatoxin B1-induced DNA adduct formation and p53   mutations in CYP450-expressing human liver cell lines. Carcinogenesis. 1997;18:1291-7.    PMID: 9230270

[76]  Peng X, Zhengqiang Y, Liang N, Chi XLi XJiang M. The mitochondrial and death receptor pathways involved in the thymocyte’s apoptosis induced by aflatoxin B1. Oncotarget. 2016;7(11):12222–34. DOI: 10.18632/oncotarget.7731.      

[77]   Chen j, Chen K, Yuan S et al. Effects of aflatoxin B1 on oxidative stress markers and     apoptosis of spleens in boilers. Toxicol Ind Health. 2016;32:278-84.  DOI:        10.1177/0748233713500819.

 [78]  Hokama Y, Kimura LH, Kobara TY, et al. Variation in peroxisomal enzyme levels of        peripheral leukocytes of cancer, leprosy and tuberculosis patients. Cancer Res. 1974;34:2784-  9.

[79]   Meszaros I, Goth L. Uber die katalaseaktivitat der erythrozyten von krebspatienten. In: Rapoport S, Jung F. editors. Internationales Symposium uber Struktur und Funktion der    Erythrozyten. Berlin, Acadamie Verlag; 1975:403.

[80]   Alberts B , Johnson A, Lewis J et al. Cell Death. In: Molecular Biology of the Cell,6th Ed.  Chap. 18. New York, NY: Garland Science; 2015, p. 1021.

[81]   Kroemer G, Galluzzi L, Brenner C. Mitochondrial Membrane Permeabilization in Cell     Death. Physiol. Rev. 2007;87:99-163. DOI: 10.1152/physrev.00013.2006.

[82]  Nakamura T, Goto M, Matsumoto A, Tanaka I. Inhibition of NF-kappa B transcriptional activity by alpha-tocopheryl succinate. Biofactors. 1998;7:21-30. PMID: 9523025.

[83]  Barnes PJ. Nuclear factor-kappa B. Int J Biochem Cell Biol. 1997;29:867-70. PMID: 9304801

[84]  Wang S, El-Deiry WS. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene. 2003;22:8628-33. DOI: 10.1038/sj.onc.1207232.

[85]  Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 2006;25:4798–4811. DOI: 10.1038/sj.onc.1209608.

[86]   Carozzi VA, Canta A, Chiorazzi A. Chemotherapy-induced peripheral neuropathy:       What do we know about mechanisms? Neuroscience Letters. 2015;596:90-107. DOI:            10.1016/j.neulet.2014.10.014.

[87]   Okouchi M, Ekshyyan O, Maracine M, Aw TY. Neuronal Apoptosis in      Neurodegeneration. Antioxid Redox Signal. 2007;9:1059-96. DOI: 10.1089/ars.2007.1511

[88]   Gillatt D. Antiandrogen treatments in locally advanced prostate cancer: are they all the same? J Cancer Res Clin Oncol. 2006;132 Suppl 1:S17-S26. DOI: 10.1007/s00432-006-0133-5.

 [89]  Anderson K, Simmons-Menchaca M, Lawson KA, Atkinson J, Sanders BG, Kline K.          Differential Response of Human Ovarian Cancer Cells to Induction of Apoptosis by Vitamin E Succinate and Vitamin E Analogue, α-TEA. Cancer Res. 2004;64(12):4263-9. DOI: 10.1158/0008-5472.CAN-03-2327.

[90]   Guerrouahen BS, Hahn T, Alderman Z, Curti B, Urba W, Akporiaye ET.  GMP-grade α-TEA lysine salt: a 28-Day oral toxicity and toxicokinetic study with a 28-Day recovery period in Beagle dogs. Cancer.2016;16:199. doi:  10.1186/s12885-016-2220-6.

 [91] Gruber J, Stanniek K, Krewenka C et al. Tocopheramine succinate and tocopheryl    succinate: Mechanism of mitochondrial inhibition and superoxide radical production.             Bioorg. Med. Chem. 2014; 22:684-691. DOI: 10.1016/j.bmc.2013.12.036.

[92]   Griffiths GJ. Exisulind Cell Pathways. Curr Opin Invetig Drugs. 2000;1:386-91.  PMID:   11249724.